Sonoma Pharmaceuticals, Inc. (SNOA) › Capital ExpendituresSonoma Pharmaceuticals, Inc. (SNOA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $174.0K2012: $336.0K2013: $257.0K2014: $504.0K2015: $139.0K2016: $345.0K2017: $394.0K2018: $187.0K2019: $100.0K2020: $206.0K2021: $179.0K2022: $137.0K2023: $269.0K2024: $2.0K2025: $80.0K2026: $192.0K$192.0K2011Capital Expenditures (USD)2026Fiscal YearCapital ExpendituresChange YoY2026$192.0K+140.0%2025$80.0K+3900.0%2024$2.0K-99.3%2023$269.0K+96.4%2022$137.0K-23.5%2021$179.0K-13.1%2020$206.0K+106.0%2019$100.0K-46.5%2018$187.0K-52.5%2017$394.0K+14.2%2016$345.0K+148.2%2015$139.0K-72.4%2014$504.0K+96.1%2013$257.0K-23.5%2012$336.0K+93.1%2011$174.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share